Schmitt Claus Peter, von Heyl Dorothee, Rieger Susanne, Arbeiter Klaus, Bonzel Klaus Eugen, Fischbach Michel, Misselwitz Joachim, Pieper Ann-Kathrin, Schaefer Franz
Division of Pediatric Nephrology, University Hospital for Pediatric and Adolescent Medicine, University of Heidelberg, Germany.
Nephrol Dial Transplant. 2007 Jul;22(7):2038-44. doi: 10.1093/ndt/gfm148. Epub 2007 Apr 9.
Glucose degradation products (GDP) in peritoneal dialysis (PD) solutions are toxic to the peritoneal membrane and promote the formation of advanced glycation end products (AGE), which contribute to accelerated atherosclerosis and amyloidosis. Double chamber PD solutions have a markedly reduced GDP content.
We analysed GDP and AGE kinetics in 21 children (7 months to 18 years) on automated PD in a prospective multicentre trial with randomized administration of single chamber, high-GDP and double-chamber, low-GDP dialysis solution for 12 weeks each. Total AGE fluorescence, carboxymethyllysine (CML, ELISA) and 3-deoxyglucosone (3-DG, HPLC) were measured in plasma and PD effluent during a 4 h peritoneal equilibration test. Plasma AGE profiles were assessed by size selective gel permeation chromatography and compared with 23 healthy controls.
Initial effluent 3-DG concentrations were 140+/-55 and 25+/-4 micromol/l with high- and low-GDP PD fluid, respectively and declined to 53+/-32 and 7+/-2 micromol/l within 4 h dwell time (P<0.001). The ex vivo AGE generating capacity was three times higher with the high-GDP solution and decreased significantly with dwell time. Plasma AGE levels were 1.8-7.4-fold above those of healthy controls; the elevation was most marked for the small molecular fraction (<2 kDa). Plasma AGE and CML levels were significantly higher after 12 weeks exposure to high-GDP solution (20991+/-4145 AU and 1505+/-617 ng/ml) than following treatment with low-GDP fluid (17518+/-4676 AU and 1151+/-438 ng/ml; both P<0.05). Four hour AGE clearance was higher with low-GDP solution (0.74+/-0.3 vs 0.44+/-0.15 ml/min*1.73 m2, P<0.01).
GDP are rapidly absorbed from the peritoneal cavity. Administration of PD solutions with low-GDP content reduces plasma AGE levels and may thus improve the cardiovascular risk profile of dialysed children.
腹膜透析(PD)液中的葡萄糖降解产物(GDP)对腹膜有毒性作用,并促进晚期糖基化终末产物(AGE)的形成,这会加速动脉粥样硬化和淀粉样变性。双腔PD液的GDP含量显著降低。
在一项前瞻性多中心试验中,我们分析了21名接受自动化腹膜透析的儿童(7个月至18岁)的GDP和AGE动力学,随机给予单腔、高GDP透析液和双腔、低GDP透析液,每种透析液使用12周。在4小时腹膜平衡试验期间,测量血浆和PD流出液中的总AGE荧光、羧甲基赖氨酸(CML,酶联免疫吸附测定)和3-脱氧葡萄糖酮(3-DG,高效液相色谱法)。通过尺寸排阻凝胶渗透色谱法评估血浆AGE谱,并与23名健康对照进行比较。
高GDP和低GDP腹膜透析液初始流出液中3-DG浓度分别为140±55和25±4微摩尔/升,在4小时驻留时间内分别降至53±32和7±2微摩尔/升(P<0.001)。高GDP溶液的体外AGE生成能力高3倍,且随驻留时间显著降低。血浆AGE水平比健康对照高1.8 - 7.4倍;小分子部分(<2 kDa)升高最为明显。暴露于高GDP溶液12周后,血浆AGE和CML水平(20991±4145 AU和1505±617纳克/毫升)显著高于低GDP溶液治疗后(17518±4676 AU和1151±438纳克/毫升;均P<0.05)。低GDP溶液的4小时AGE清除率更高(0.74±0.3对0.44±0.15毫升/分钟·1.73平方米,P<0.01)。
GDP可迅速从腹腔吸收。给予低GDP含量的腹膜透析液可降低血浆AGE水平,从而可能改善接受透析儿童的心血管风险状况。